Evidence map›Paper›PMID 29800044›Full record

ArticleJAMA oncology2018

Association of Patient Sex With Chemotherapy-Related Toxic Effects: A Retrospective Analysis of the PETACC-3 Trial Conducted by the EORTC Gastrointestinal Group.

Valerie Cristina, Jestinah Mahachie, Murielle Mauer, Thierry Buclin, Eric Van Cutsem, Arnaud Roth, Anna D Wagner

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Gut-derivediMeta · 2025
    Article
  8. Observational
  9. [Sex differences in pancreatic cancer].Chirurgie (Heidelberg, Germany) · 2024
    Review
  10. Article
  11. Review
  12. [Sex-specific differences of special tumor diseases].Innere Medizin (Heidelberg, Germany) · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Valerie CristinaDepartment of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
Jestinah MahachieStatistics Department, EORTC Headquarters, Brussels, Belgium.
Murielle MauerStatistics Department, EORTC Headquarters, Brussels, Belgium.
Thierry BuclinDepartment of Clinical Pharmacology, Lausanne University Hospital, Lausanne, Switzerland.
Eric Van CutsemDepartment of Digestive Oncology, University Hospitals Leuven and KU, Leuven, Belgium.
Arnaud RothDepartment of Oncology, Hôpitaux Universitaire de Genève, Geneva, Switzerland.
Anna D WagnerDepartment of Oncology, Lausanne University Hospital, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gender IdentityAgedDrug-Related Side Effects and Adverse ReactionsDrug TherapyFemaleGastrointestinal NeoplasmsHumansMaleMiddle AgedRetrospective Studies

Identifiers

PMID29800044
PMCPMC6145725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.